Novo Nordisk (NVO) Stock Gains After Company Exits $10 Billion Metsera Bidding War

TLDR Novo Nordisk withdrew from the $10 billion bidding war for Metsera after Pfizer secured the deal, with investors relieved over concerns about Novo’s complex offer structure Novo Nordisk stock rose 2.6% on Monday following the exit from the Metsera acquisition attempt The U.S. Federal Trade Commission warned that Novo’s proposed deal risked violating antitrust [...]

The post Novo Nordisk (NVO) Stock Gains After Company Exits $10 Billion Metsera Bidding War appeared first on Blockonomi.